Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MTND2P38 is a pseudogene located on human chromosome 8 (8q11.1). Pseudogenes are DNA sequences that resemble functional genes but have lost their protein-coding ability through mutations or deletions; they are often evolutionary remnants and generally do not produce functional proteins. MTND2P38 shares sequence homology with the mitochondrial gene MT-ND2, which encodes a subunit of NADH:ubiquinone oxidoreductase (Complex I) of the mitochondrial respiratory chain. Unlike the functional ND2 gene, MTND2P38 does not participate in biological processes, is not implicated in disease, and is not a therapeutic target or druggable entity. If your intent was to find a therapeutic target for mitochondrial NADH dehydrogenase activity, refer to the functional mitochondrial gene MT-ND2 instead. MTND2P38 should not be considered a valid drug target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 2 pseudogene 38 (MTND2P38).